• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏淀粉样变性:在一名亚洲女性中发现的罕见转甲状腺素蛋白突变

Cardiac Amyloidosis: A Rare TTR Mutation Found in an Asian Female.

作者信息

Mouksian Kristina, Ammon Jessica, Pullen Drenda, Zhang Qiuhua, Yedlapati Neeraja, Jefferies John Lynn

机构信息

Department of Internal Medicine, Division of Cardiovascular Disease, University of Tennessee Health Science Center, Memphis, TN 38103, USA.

Methodist Le Bonheur Healthcare, Memphis, TN 38104, USA.

出版信息

J Cardiovasc Dev Dis. 2023 Jan 1;10(1):13. doi: 10.3390/jcdd10010013.

DOI:10.3390/jcdd10010013
PMID:36661908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9863331/
Abstract

BACKGROUND

Transthyretin cardiac amyloidosis (ATTR) is a life-threatening, debilitating disease caused by abnormal formation and deposit of transthyretin (TTR) protein in multiple tissues, including myocardial extracellular matrix. It can be challenging to diagnose due to the myriad of presenting signs and symptoms. Additionally, numerous TTR mutations exist in certain ethnicities. Interestingly, our patient was discovered to have a very rare Gly67Ala TTR mutation typically not found in individuals of Asian descent. Recent advances in cardiovascular imaging techniques have allowed for earlier recognition and, therefore, management of this disease. Although incurable, there are now new, emerging treatments that are available for symptom control of cardiac amyloidosis, making early diagnosis vital for these patients, specifically their quality of life.

CASE SUMMARY

We outline a case of a 50-year-old Asian female who was initially hospitalized for nausea and vomiting and persistent orthostatic hypotension. She underwent a multitude of laboratory and imaging tests, resulting in a diagnosis of cardiac amyloidosis, which was confirmed to be due to a rare TTR mutation via genetic testing.

CONCLUSIONS

Our objective is to describe various TTR mutations, existing diagnostic imaging modalities, and available treatments, as well as highlight the importance of early screening and awareness of cardiac amyloidosis, allowing for quicker diagnosis and treatment of this disease.

摘要

背景

转甲状腺素蛋白心脏淀粉样变(ATTR)是一种危及生命、使人衰弱的疾病,由转甲状腺素蛋白(TTR)在包括心肌细胞外基质在内的多个组织中异常形成和沉积所致。由于其表现出的众多体征和症状,诊断可能具有挑战性。此外,在某些种族中存在大量TTR突变。有趣的是,我们的患者被发现有一种非常罕见的Gly67Ala TTR突变,这种突变在亚洲血统个体中通常不存在。心血管成像技术的最新进展使得能够更早地识别并因此管理这种疾病。尽管无法治愈,但现在有新出现的治疗方法可用于控制心脏淀粉样变的症状,这使得早期诊断对这些患者,特别是对他们的生活质量至关重要。

病例总结

我们概述了一例50岁亚洲女性的病例,她最初因恶心、呕吐和持续性直立性低血压住院。她接受了多项实验室和影像学检查,诊断为心脏淀粉样变,通过基因检测证实是由一种罕见的TTR突变引起的。

结论

我们的目的是描述各种TTR突变、现有的诊断成像方式和可用的治疗方法,以及强调早期筛查和认识心脏淀粉样变的重要性,以便更快地诊断和治疗这种疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f693/9863331/64ea3b324bff/jcdd-10-00013-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f693/9863331/804d2bf41b5c/jcdd-10-00013-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f693/9863331/3f8e4a307310/jcdd-10-00013-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f693/9863331/bc6add89a461/jcdd-10-00013-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f693/9863331/62b259eb7bb2/jcdd-10-00013-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f693/9863331/2f9c609f5496/jcdd-10-00013-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f693/9863331/f581f3a2e6c0/jcdd-10-00013-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f693/9863331/64ea3b324bff/jcdd-10-00013-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f693/9863331/804d2bf41b5c/jcdd-10-00013-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f693/9863331/3f8e4a307310/jcdd-10-00013-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f693/9863331/bc6add89a461/jcdd-10-00013-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f693/9863331/62b259eb7bb2/jcdd-10-00013-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f693/9863331/2f9c609f5496/jcdd-10-00013-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f693/9863331/f581f3a2e6c0/jcdd-10-00013-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f693/9863331/64ea3b324bff/jcdd-10-00013-g007.jpg

相似文献

1
Cardiac Amyloidosis: A Rare TTR Mutation Found in an Asian Female.心脏淀粉样变性:在一名亚洲女性中发现的罕见转甲状腺素蛋白突变
J Cardiovasc Dev Dis. 2023 Jan 1;10(1):13. doi: 10.3390/jcdd10010013.
2
Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis.转甲状腺素蛋白(ATTR)心脏淀粉样变性中基因检测的影响
Curr Heart Fail Rep. 2019 Oct;16(5):180-188. doi: 10.1007/s11897-019-00436-z.
3
A rare variant of transthyretin-related amyloidosis associated with exclusive cardiomyopathy in a Hong Kong Chinese patient.一名香港华裔患者中与单纯性心肌病相关的转甲状腺素蛋白相关淀粉样变性的罕见变异型。
J Cardiol Cases. 2018 Oct 22;18(6):185-188. doi: 10.1016/j.jccase.2018.07.011. eCollection 2018 Dec.
4
Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G).以 ATTR A45G 淀粉样变性引起的新型 TTR 突变(p.A65G)为首发表现的迟发性心肌病。
Cardiovasc Pathol. 2017 Jul-Aug;29:19-22. doi: 10.1016/j.carpath.2017.04.002. Epub 2017 Apr 18.
5
A case of cardiac amyloidosis in an elderly Japanese patient with amyloidogenic transthyretin Val122Ile variant.一名患有淀粉样前体蛋白缬氨酸122异亮氨酸变异体的老年日本心脏淀粉样变性患者的病例。
J Cardiol Cases. 2020 Jul 29;22(5):221-225. doi: 10.1016/j.jccase.2020.07.010. eCollection 2020 Nov.
6
Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis.波兰人心血管甲状腺素运载蛋白淀粉样变性患者的转甲状腺素蛋白基因突变谱及临床特征。
Cardiol J. 2022;29(6):985-993. doi: 10.5603/CJ.a2020.0104. Epub 2020 Aug 13.
7
Hereditary transthyretin amyloidosis presenting with spontaneous periorbital purpura: a case report.以自发性眶周紫癜为表现的遗传性转甲状腺素蛋白淀粉样变性:一例报告
Eur Heart J Case Rep. 2023 Mar 6;7(3):ytad108. doi: 10.1093/ehjcr/ytad108. eCollection 2023 Mar.
8
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.专家共识建议:疑似转甲状腺素蛋白心脏淀粉样变性的诊断。
Circ Heart Fail. 2019 Sep;12(9):e006075. doi: 10.1161/CIRCHEARTFAILURE.119.006075. Epub 2019 Sep 4.
9
Challenges in the approach to a patient with aortic stenosis and cardiac amyloidosis with ATTR mutation associated with negative scintigraphy - A case report.伴有与阴性闪烁扫描相关的ATTR突变的主动脉瓣狭窄和心脏淀粉样变性患者的治疗挑战——病例报告
Am Heart J Plus. 2024 Aug 21;45:100444. doi: 10.1016/j.ahjo.2024.100444. eCollection 2024 Sep.
10
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms.无心力衰竭症状的转甲状腺素蛋白心脏淀粉样变的预后
JACC CardioOncol. 2022 Nov 15;4(4):442-454. doi: 10.1016/j.jaccao.2022.07.007. eCollection 2022 Nov.

引用本文的文献

1
Advances in the Diagnosis and Management of Cardiac Amyloidosis: A Literature Review.心脏淀粉样变的诊断与管理进展:文献综述
Cardiol Res. 2024 Aug;15(4):211-222. doi: 10.14740/cr1664. Epub 2024 Jul 18.

本文引用的文献

1
Cardiac Amyloidosis Treatment.心脏淀粉样变性的治疗。
Methodist Debakey Cardiovasc J. 2022 Mar 14;18(2):59-72. doi: 10.14797/mdcvj.1050. eCollection 2022.
2
Light Chain Amyloidosis: Epidemiology, Staging, and Prognostication.轻链淀粉样变性:流行病学、分期和预后。
Methodist Debakey Cardiovasc J. 2022 Mar 14;18(2):27-35. doi: 10.14797/mdcvj.1070. eCollection 2022.
3
The genetics of cardiac amyloidosis.心脏淀粉样变性的遗传学。
Heart Fail Rev. 2022 Sep;27(5):1485-1492. doi: 10.1007/s10741-021-10164-z. Epub 2021 Sep 13.
4
AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management.心脏病专家和肿瘤学家的AL型淀粉样变性:流行病学、诊断与管理
JACC CardioOncol. 2019 Sep 24;1(1):117-130. doi: 10.1016/j.jaccao.2019.08.002. eCollection 2019 Sep.
5
Hereditary Transthyretin Amyloidosis- Clinical and Genetic Characteristics of a Multiracial South-East Asian Cohort in Singapore.遗传性转甲状腺素蛋白淀粉样变性症-新加坡多民族东南亚队列的临床和遗传特征。
J Neuromuscul Dis. 2021;8(4):723-733. doi: 10.3233/JND-210656.
6
Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities?轻链淀粉样变性中的室性快速性心律失常与心源性猝死:两种心脏毒性的冲突?
Br J Haematol. 2021 May;193(4):e27-e31. doi: 10.1111/bjh.17399. Epub 2021 Apr 11.
7
Cardiac amyloidosis-A review of current literature for the practicing physician.心脏淀粉样变——临床医生实用文献复习
Clin Cardiol. 2021 Mar;44(3):322-331. doi: 10.1002/clc.23572. Epub 2021 Feb 17.
8
Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee.淀粉样变命名 2020:国际淀粉样变协会(ISA)命名委员会的更新和建议。
Amyloid. 2020 Dec;27(4):217-222. doi: 10.1080/13506129.2020.1835263. Epub 2020 Oct 26.
9
Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies.转甲状腺素蛋白淀粉样变性:临床谱、发病机制及疾病修饰疗法的最新进展
Neurol Ther. 2020 Dec;9(2):317-333. doi: 10.1007/s40120-020-00210-7. Epub 2020 Sep 18.
10
The Pathology of Amyloidosis in Classification: A Review.淀粉样变的病理学分类:综述。
Acta Haematol. 2020;143(4):322-334. doi: 10.1159/000506696. Epub 2020 May 11.